Key Takeaways Abbott's Q3 adjusted EPS missed estimates by 0.7%, while sales rose 14.5% to $13.01 billion.Abbott's Medical Devices and Diagnostics posted growth, while Nutrition sales rose 4.9% on a comparable basis.Abbott expanded gross and operating margins but lowered its 2026 comparable sales growth outlook to 6%.Abbott (ABT) reported third-quarter 2026 adjusted earnings per share of $1.42, up 9.2% year over year. The figure missed the Zacks Consensus Estimate by 0.7%.Sales increased 14.5% year over yea ...